On the other hand, c-Myc, a well-recognized downstream factor of β-catenin, transcriptionally controls many essential elements driving cancer metabolic reprograming, such as forkhead transcription factors, GLUT1, and PKM224,25. This evidence concerns the gene MYC and cancer.